Top insider buys: Jan 13 – Jan 19, 2025

The largest open-market purchases company insiders reported on SEC Form 4 between Jan 13 – Jan 19, 2025.

Week 3, 2025

#	Company	Who bought	Shares	Value	Source
1	NEOG NEOGEN CORP	2 officers/directors Cluster buy David H. Naemura, John Edward Adent	37,835	$419K	SEC filings
2	IMVT Immunovant, Inc.	Director Roivant Sciences Ltd.	16,845,010	$336.9M	SEC filings
3	PDX PIMCO Dynamic Income Strategy Fund	10% Owner Saba Capital Management, L.P.	731,721	$20.2M	SEC filings
4	MODV ModivCare Inc	10% Owner Coliseum Capital Management, LLC	1,502,424	$10.0M	SEC filings
5	PBF PBF Energy Inc.	10% Owner Empresarial De Capitales S.a. De C.v. Control	100,000	$2.9M	SEC filings
6	DBI Designer Brands Inc.	Insider Stone House Capital Management, LLC	500,000	$2.8M	SEC filings
7	FLWS 1 800 FLOWERS COM INC	10% Owner Fund 1 Investments, LLC	368,000	$2.7M	SEC filings
8	ZYME Zymeworks Inc.	Director EcoR1 Capital, LLC	167,654	$2.3M	SEC filings
9	OLMA Olema Pharmaceuticals, Inc.	10% Owner Bain Capital Life Sciences Investors, LLC	300,000	$1.7M	SEC filings
10	NRIS Norris Industries, Inc.	Chairman, CEO, CFO Patrick L. Norris	17,362,675	$1.4M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.